Lower extremity lipedema, upper extremity lipodystrophy and severe calcinosis complicating juvenile dermatomyositis

Slavica R Pavlov-Dolijanovic1, Nada Z Vujasinovic Stupar, Nikola Gavrilov

  • 1Institute of Rheumatology Belgrade, Resavska 69, Belgrade, Serbia, dolijan@eunet.rs.

Insights

Juvenile dermatomyositis (JDM) can cause significant complications, including lipodystrophy and lipedema. This case highlights a rare presentation of JDM with co-occurring lipedema and lipodystrophy, raising questions about autoimmune disease overlap.

Area of Science:

  • Rheumatology
  • Pediatric Autoimmunology
  • Dermatology

Background:

  • Juvenile dermatomyositis (JDM) is a rare autoimmune disease in children, often leading to chronic complications like muscle atrophy, contractures, and calcinosis.
  • Recent reports suggest potential body fat redistribution in JDM patients, with the nature of this lipodystrophy, particularly its relation to lower extremity lipedema, remaining unclear.

Observation:

  • A 39-year-old woman, diagnosed with JDM at age 7, presented with symmetrical upper extremity lipodystrophy and lower extremity lipedema.
  • She also had progressive, subcutaneous calcified nodules and scleroderma-like capillaroscopy findings.
  • Positive ANA and anti-U1RNP antibodies were noted during her follow-up.

Findings:

  • This case represents a unique simultaneous occurrence of lower extremity lipedema, upper extremity lipodystrophy, and severe calcinosis in a JDM patient.
  • Calcinosis and lipodystrophy were found to be associated with a shorter duration of active JDM disease.
  • The patient's presentation suggests a potential for overlapping autoimmune conditions during the long-term follow-up of JDM.

Implications:

  • This case expands the known clinical spectrum of JDM complications, particularly regarding body fat redistribution and its association with lipedema.
  • It underscores the importance of recognizing and investigating complex presentations in JDM, including potential co-existing autoimmune disorders.
  • Further research is warranted to understand the pathogenesis and management of these rare JDM-associated conditions.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
1.6K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
659